Relationship of interleukin-8 gene polymorphisms with hepatocellular carcinoma susceptibility and pathological development

Journal of Surgical Oncology

Volumn 104, Issue 7, 2011, Pages 798-803

  Chien, Ming Hsien ^a,b   Yeh, Chao Bin ^c,d   Li, Yi Ching ^c   Wei, Lin Hung ^e   Chang, Jer Hwa ^a   Peng, Yu Ting ^c   Yang, Shun Fa ^c,d   Kuo, Wu Hsien ^f,g,h  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f TAICHUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^g HUALIEN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^h CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

genetic polymorphism; hepatocellular carcinoma; interleukin 8

Indexed keywords

INTERLEUKIN 8;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-8; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; TAIWAN;

EID: 80255124785     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22037     Document Type: Article

References (53)

1. Bosch FX, Ribes J, Cleries R, et al.: Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005; 9: 191-211.
2. Hsiao PC, Chen MK, Su SC, et al.: Hypoxia inducible factor-1alpha gene polymorphism G1790A and its interaction with tobacco and alcohol consumptions increase susceptibility to hepatocellular carcinoma. J Surg Oncol 2010; 102: 163-169.
3. Farazi PA, DePinho RA,: Hepatocellular carcinoma pathogenesis: From genes to environment. Nat Rev Cancer 2006; 6: 674-687. (Pubitemid 44286000)
4. Firpi RJ, Nelson DR,: Viral hepatitis: Manifestations and management strategy. Hematology Am Soc Hematol Educ Program 2006; 375-380.
5. Yano Y, Yamashita F, Kuwaki K, et al.: Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II. Liver Int 2006; 26: 789-795. (Pubitemid 44165246)
6. Akkiz H, Bayram S, Bekar A, et al.: G-308A TNF-alpha polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: Case-control study. Cancer Epidemiol 2009; 33: 261-264.
7. Chang CC, Chen SC, Hsieh YH, et al.: Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma. Clin Chem Lab Med 2009; 47: 412-418.
8. Chien MH, Yeh KT, Li YC, et al.: Effects of E-cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathological development of hepatocellular carcinoma. J Surg Oncol 2011 (in press).
9. Hull J, Ackerman H, Isles K, et al.: Unusual haplotypic structure of IL8, a susceptibility locus for a common respiratory virus. Am J Hum Genet 2001; 69: 413-419. (Pubitemid 32695212)
10. Matsushima K, Oppenheim JJ,: Interleukin 8 and MCAF: Novel inflammatory cytokines inducible by IL 1 and TNF. Cytokine 1989; 1: 2-13.
11. Baggiolini M, Walz A, Kunkel SL,: Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989; 84: 1045-1049. (Pubitemid 19247571)
12. Harada A, Sekido N, Akahoshi T, et al.: Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol 1994; 56: 559-564. (Pubitemid 24348812)
13. Benoy IH, Salgado R, Van Dam P, et al.: Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clin Cancer Res 2004; 10: 7157-7162. (Pubitemid 39487700)
14. Brew R, Erikson JS, West DC, et al.: Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 2000; 12: 78-85. (Pubitemid 30042685)
15. Kim SJ, Uehara H, Karashima T, et al.: Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice. Neoplasia 2001; 3: 33-42. (Pubitemid 32201608)
16. Boldrini L, Gisfredi S, Ursino S, et al.: Interleukin-8 in non-small cell lung carcinoma: Relation with angiogenic pattern and p53 alterations. Lung Cancer 2005; 50: 309-317.
17. Ren Y, Poon RT, Tsui HT, et al.: Interleukin-8 serum levels in patients with hepatocellular carcinoma: Correlations with clinicopathological features and prognosis. Clin Cancer Res 2003; 9: 5996-6001. (Pubitemid 38018086)
18. Wang Y, Yang J, Gao Y, et al.: Regulatory effect of e2, IL-6 and IL-8 on the growth of epithelial ovarian cancer cells. Cell Mol Immunol 2005; 2: 365-372.
19. Mukaida N, Shiroo M, Matsushima K,: Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J Immunol 1989; 143: 1366-1371. (Pubitemid 19211374)
20. Hull J, Thomson A, Kwiatkowski D,: Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 2000; 55: 1023-1027.
21. Ohyauchi M, Imatani A, Yonechi M, et al.: The polymorphism interleukin 8-251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 2005; 54: 330-335. (Pubitemid 40299086)
22. Taguchi A, Ohmiya N, Shirai K, et al.: Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev 2005; 14: 2487-2493. (Pubitemid 41752706)
23. Lee WP, Tai DI, Lan KH, et al.: The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin Cancer Res 2005; 11: 6431-6441.
24. Smith KC, Bateman AC, Fussell HM, et al.: Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. Eur J Immunogenet 2004; 31: 167-173. (Pubitemid 39049861)
25. Snoussi K, Mahfoudh W, Bouaouina N, et al.: Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma. Hum Immunol 2006; 67: 13-21. (Pubitemid 43673908)
26. Snoussi K, Mahfoudh W, Bouaouina N, et al.: Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness. BMC Cancer 2010; 10: 283.
27. Cacev T, Radosevic S, Krizanac S, et al.: Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. Carcinogenesis 2008; 29: 1572-1580.
28. Yang HP, Woodson K, Taylor PR, et al.: Genetic variation in interleukin 8 and its receptor genes and its influence on the risk and prognosis of prostate cancer among Finnish men in a large cancer prevention trial. Eur J Cancer Prev 2006; 15: 249-253. (Pubitemid 43791771)
29. Zhang J, Dhakal IB, Lang NP, et al.: Polymorphisms in inflammatory genes, plasma antioxidants, and prostate cancer risk. Cancer Causes Control 2010; 21: 1437-1444.
30. Campa D, Hung RJ, Mates D, et al.: Lack of association between -251 T > A polymorphism of IL8 and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2005; 14: 2457-2458. (Pubitemid 41437853)
31. Wei YS, Lan Y, Tang RG, et al.: Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma. Clin Immunol 2007; 125: 309-317. (Pubitemid 350116706)
32. Leibovici D, Grossman HB, Dinney CP, et al.: Polymorphisms in inflammation genes and bladder cancer: From initiation to recurrence, progression, and survival. J Clin Oncol 2005; 23: 5746-5756.
33. Shimizu Y, Kondo S, Shirai A, et al.: A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer. Auris Nasus Larynx 2008; 35: 381-389.
34. Vogel U, Christensen J, Wallin H, et al.: Polymorphisms in COX-2, NSAID use and risk of basal cell carcinoma in a prospective study of Danes. Mutat Res 2007; 617: 138-146. (Pubitemid 46386090)
35. Vairaktaris E, Yapijakis C, Serefoglou Z, et al.: The interleukin-8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma. Eur J Surg Oncol 2007; 33: 504-507. (Pubitemid 46620664)
36. Howell WM, Turner SJ, Theaker JM, et al.: Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma. Eur J Immunogenet 2003; 30: 409-414. (Pubitemid 38019299)
37. van der Kuyl AC, Polstra AM, Weverling GJ, et al.: An IL-8 gene promoter polymorphism is associated with the risk of the development of AIDS-related Kaposi's sarcoma: A case-control study. AIDS 2004; 18: 1206-1208. (Pubitemid 38738522)
38. Heinzmann A, Ahlert I, Kurz T, et al.: Association study suggests opposite effects of polymorphisms within IL8 on bronchial asthma and respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol 2004; 114: 671-676. (Pubitemid 39194946)
39. Puthothu B, Krueger M, Heinze J, et al.: Impact of IL8 and IL8-receptor alpha polymorphisms on the genetics of bronchial asthma and severe RSV infections. Clin Mol Allergy 2006; 4: 2.
40. Dan H, Liu W, Zhou Y, et al.: Association of interleukin-8 gene polymorphisms and haplotypes with oral lichen planus in a Chinese population. Inflammation 2010; 33: 76-81.
41. Artifoni L, Negrisolo S, Montini G, et al.: Interleukin-8 and CXCR1 receptor functional polymorphisms and susceptibility to acute pyelonephritis. J Urol 2007; 177: 1102-1106. (Pubitemid 46216366)
42. Amoli MM, Thomson W, Hajeer AH, et al.: Interleukin 8 gene polymorphism is associated with increased risk of nephritis in cutaneous vasculitis. J Rheumatol 2002; 29: 2367-2370. (Pubitemid 35266027)
43. Uslu R, Sanli UA, Dikmen Y, et al.: Predictive value of serum interleukin-8 levels in ovarian cancer patients treated with paclitaxel-containing regimens. Int J Gynecol Cancer 2005; 15: 240-245. (Pubitemid 40396959)
44. Gokhale AS, Haddad RI, Cavacini LA, et al.: Serum concentrations of interleukin-8, vascular endothelial growth factor, and epidermal growth factor receptor in patients with squamous cell cancer of the head and neck. Oral Oncol 2005; 41: 70-76. (Pubitemid 39647122)
45. Lehrer S, Diamond EJ, Mamkine B, et al.: Serum interleukin-8 is elevated in men with prostate cancer and bone metastases. Technol Cancer Res Treat 2004; 3: 411. (Pubitemid 39391995)
46. Savage SA, Hou L, Lissowska J, et al.: Interleukin-8 polymorphisms are not associated with gastric cancer risk in a Polish population. Cancer Epidemiol Biomarkers Prev 2006; 15: 589-591.
47. Gao LB, Pan XM, Jia J, et al.: IL-8-251A/T polymorphism is associated with decreased cancer risk among population-based studies: Evidence from a meta-analysis. Eur J Cancer 2010; 46: 1333-1343.
48. Wang JY, Wang XL, Liu P,: Detection of serum TNF-alpha,IFN-beta,I L-6 and IL-8 in patients with hepatitis. World J Gastroenterol 1999; 5: 38-40.
49. Shin EC, Choi YH, Kim JS, et al.: Expression patterns of cytokines and chemokines genes in human hepatoma cells. Yonsei Med J 2002; 43: 657-664. (Pubitemid 35282889)
50. Mahe Y, Mukaida N, Kuno K, et al.: Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements. J Biol Chem 1991; 266: 13759-13763. (Pubitemid 21907416)
51. Kamangar F, Abnet CC, Hutchinson AA, et al.: Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control 2006; 17: 117-125. (Pubitemid 43084810)
52. Song B, Zhang D, Wang S, et al.: Association of interleukin-8 with cachexia from patients with low-third gastric cancer. Comp Funct Genomics 2009; 212345.
53. Poli V,: The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J Biol Chem 1998; 273: 29279-29282. (Pubitemid 28509923)